Results on the effect of cytoplasmic FUCA-1, Ki67, ER, PR on survival in our cohort of LN+ BC patients are summarized in Supplementary Table 3, where p values refer to log-rank test obtained for cytoplasmic expression of FUCA-1 in LN+ BC patients positive for the marked biomarkers. This evidence concerns the gene PGR and breast cancer.